Stocks and Investing Stocks and Investing
Wed, June 12, 2024
Tue, June 11, 2024

Andy Chen Initiated (AKRO) at Buy on, Jun 11th, 2024


Published on 2024-10-28 11:53:15 - WOPRAI, Andy Chen
  Print publication without navigation


Andy Chen of Wolfe Research, Initiated "Akero Therapeutics, Inc." (AKRO) at Buy on, Jun 11th, 2024.

Andy has made no other calls on AKRO in the last 4 months.



There are 4 other peers that have a rating on AKRO. Out of the 4 peers that are also analyzing AKRO, 1 agrees with Andy's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Alexandria Hammond of "B of A Securities" Initiated at Hold and Held Target at $30 on, Monday, April 22nd, 2024


These are the ratings of the 3 analyists that currently disagree with Andy


  • Liisa Bayko of "Evercore ISI Group" Maintained at Buy with Decreased Target to $38 on, Wednesday, May 15th, 2024
  • Edward Nash of "Canaccord Genuity" Maintained at Strong Buy with Decreased Target to $56 on, Monday, May 13th, 2024
  • Eliana Merle of "UBS" Maintained at Strong Buy with Increased Target to $42 on, Tuesday, March 5th, 2024
Contributing Sources